PathoQuest

Paris, France

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

$17.4M raised

Nov 2021

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PathoQuest raised?

PathoQuest has raised $17.4M in total funding. The most recent round was Series B. The last funding was announced in November 2021.

Who are PathoQuest's investors?

PathoQuest's investors include Kurma Partners, Eurazeo, Verve Ventures, Charles River Laboratories International, Idinvest Partners.

Where is PathoQuest headquartered?

PathoQuest is headquartered in Paris, France.

What does PathoQuest do?

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

What stage is PathoQuest at?

PathoQuest is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 9, 2021.

MLA

"PathoQuest — Funding & Investors." VCBacked, November 9, 2021, https://www.vcbacked.co/company/pathoquest. Accessed July 4, 2026.

APA

VCBacked. (2021). PathoQuest — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/pathoquest

Wikipedia (cite web)

{{cite web |title=PathoQuest — Funding & Investors |url=https://www.vcbacked.co/company/pathoquest |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 9, 2021.